4-(6-Oxo-1,6-dihydropyridazin-3-yl)benzoic acid, 95%, 1g

Acide L(+)-tartrique, min 99,7 %, pour la biochimie, 5 kg, emballage plastique.

3,5-Dichloro-2-(piperidin-4-yl)pyridine, 97.0%, 100mg

6-(Trifluoromethyl)uracil, 97.0%, 100g

5-(2,4-Dimethylphenyl)-1,3-thiazol-2-amine, 95%, 500mg

2,4-Dichlorophenylacetylene, 97.0%, 5g

2-(4-(Trifluoromethoxy)phenyl)pyrrolidine hydrochloride, 95.0%, 250mg

(2S,3R)-1-[(tert-Butoxy)carbonyl]-3-fluoropyrrolidine-2-carboxylic acid, 97%, 250mg

3-(4-Chloro-phenyl)-prop-2-yn-1-ol, 5g

2-tert-Butyloxycarbonylaminomethyl-5-methyl-[1,3,4]oxadiazole, 95.0%, 5g

2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carbaldehyde, 98%, 250mg

1H-Indazol-4-ol, 95.0%, 5g

6-ethyl-N-[3-(1H-imidazol-1-yl)propyl]-1,3-benzothiazol-2-amine, 95.0%, 250mg